Nanalysis Announces Second Quarter 2023 Conference Call

Rhea-AI Summary

Nanalysis Scientific Corp. will release its quarterly results for the period ending June 30, 2023. A conference call will be hosted by CEO Sean Krakiwsky and CFO Randall McRae on August 24th at 5:00 pm ET. A Q&A session for European investors will also be held on August 25th at 8:30 am ET.

Hosting Call at 5:00 pm ET on Thursday, August 24th

European Q&A Session on August 25th at 8:30am ET

CALGARY, AB, Aug. 15, 2023 /PRNewswire/ -Nanalysis Scientific Corp. ("the Company"), (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Thursday, August 24th, 2023, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ending June 30, 2023. 

Investors interested in participating in the live full year call can dial 1-888-664-6392 or 416-764-8659 from abroad. Investors can also access the call online through a listen-only webcast here: https://app.webinar.net/mbeN7MlYQon or on the investor relations section of the Company's website HERE.

The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-390-0541 or 416-764-8677, conference ID #309928.

Additionally, the Company will be hosting a Q&A session for it's European investors at 8:30am ET on Friday, August 25th which can be accessed by the following link: Click here to join the meeting or call in (audio only) +1 437-703-4522, Phone Conference ID: 899 910 303#.

About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)

Nanalysis' business is what we term "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020 Nanalysis announced the launch of its100MHz device, the most powerful and most advanced compact NMR device ever brought to market.

Nanalysis' devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.

In 2022 the Company acquired K'(Prime) Technologies Inc. (K'Prime), a North American sales and service company which provides sales services for scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications. K'Prime's service organization provides airport and commercial security installation and maintenance solutions across North America.

Additionally in 2022, the Company acquired a 43% ownership in Quad Systems AG ("Quad Systems"), a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-second-quarter-2023-conference-call-301900661.html

SOURCE Nanalysis Scientific Corp.

FAQ

When will Nanalysis Scientific Corp. release its quarterly results?

Nanalysis Scientific Corp. will release its quarterly results on August 24th.

Who will host the conference call?

The conference call will be hosted by CEO Sean Krakiwsky and CFO Randall McRae.

What is the date and time of the conference call?

The conference call will take place on August 24th at 5:00 pm ET.

How can investors participate in the conference call?

Investors can dial 1-888-664-6392 or 416-764-8659 from abroad to participate in the conference call.

Is there an online option to access the conference call?

Yes, investors can access the call online through a listen-only webcast at https://app.webinar.net/mbeN7MlYQon or on the investor relations section of the company's website.

Will the conference call be archived?

Yes, the webcast will be archived on the company's investor relations webpage for at least 90 days. A telephonic playback will also be available for seven days after the conference call by calling 1-888-390-0541 or 416-764-8677, conference ID #309928.

When is the Q&A session for European investors?

The Q&A session for European investors will be held on August 25th at 8:30 am ET.

How can European investors join the Q&A session?

European investors can join the session by clicking on the provided link or calling in for audio only at +1 437-703-4522, Phone Conference ID: 899 910 303#.